VP (Research and International Relations) news
Raptor Pharmaceutical recently announced that it has acquired exclusive rights to intellectual property related to cysteamine and related compounds in the potential treatment of parasitic diseases, including malaria, from McGill.
BioFuelNet Canada – made possible by federal NCE program – will bring together industry and academics to research and develop biofuels of the future
McGill and AMURE met on May 16 and signed off on the final English and French versions of seven articles in the Research Associates and Research Assistants collective agreements.
At the meeting of both parties on May 2, the union proposed a few changes and agreed to the English and French versions of the texts relating to the seven articles on which there have been agreements since the start of negotiations. These texts will be signed by both parties at the next meeting.
Prof. Ehab Abouheif, Dept. of Biology and a research team investigated which genes were being expressed during the development of antennae in male water striders. The antennae are used to grasp the females during mating. They then modified gene expression to see how this would be expressed in antennae development and success in mating. By doing so they were able to watch evolution in action.
Dr. Rose Goldstein, Vice-Principal (Research and International Relations), is proud to announce that Prof. Sarah Stroud has been appointed Associate Vice-Principal (Research and International Relations), effective May 1, 2012. In this role, Prof. Stroud will focus on supporting McGill research in the humanities and social sciences.
McGill University is building on longstanding research collaborations with Brazil by announcing four partnership agreements with Brazilian universities. These agreements are being signed this week by Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University.
A new study by Carsten Wrosch of Concordia University and Catherine Sabiston of McGill’s Department of Kinesiology and Physical Education found that breast cancer survivors who were able to let go of old exercise goals and set new ones increased their level of physical activity and showed an improved well-being overall.
The McGill University and Génome Québec Innovation Centre is pleased to announce that they have been awarded funding totalling $7.6 million over a two-year period from Genome Canada’s 2010 Competition. This award, a record for Québec, will fund the operations of the Innovation Centre as well as the services offered to scientific communities in Québec, the rest of Canada and around the world.